Why the study?
Type III endoleaks after EVAR carry a high risk of aortic rupture and may occur at any time, with ongoing improvements needed to optimize patient prognoses.
This case report highlights the use of endovascular stent-graft placement as a treatment for high-risk type III endoleaks following EVAR.
Case of post-EVAR type III endoleak with rupture; leaves open optimal surveillance intervals and timing of reintervention.
Endovascular treatment of abdominal aortic aneurysm concerns the introduction of aortic endoprosthesis which aims to isolate aneurysm from the circulation. The leading complication of this technique is the endoleak which is defined by the persistence of blood flow within the aneurysm sac. The main risk is the rupture of the aorta which can jeopardize the vital prognosis of patient. White classification defines five types of endoleaks. Type III is secondary either to a disconnection between the components of the endoprosthesis (type IIIA) or to material damage (type IIIB). This type presents a particularly high risk of aortic rupture. Endovascular approach is the treatment of choice for this type of endoleaks through stent-grafts implantation. Type III endoleak may appear at any time after endovascular aortic aneurysm repair (EVAR). Although the frequency of endoleak after EVAR has been reduced after improvement and development of stent-graft systems, there are still many improvements and additions expected to improve the prognoses for patients after EVAR. Our case is an 80-year-old patient, who received an EVAR in 2012 for his abdominal aortic aneurysm, admitted to our vascular surgery department for a type III endoleak, for which he benefited from an endovascular treatment by placement of stent-grafts.
No takes yet. Share an insight, caveat, or question.
Suliemeh et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: